Systematic review / meta-analysisHuman

Cerebrolysin for vascular dementia

The Cochrane database of systematic reviews, 2019 Nov 11. Cui S, Chen N, Yang M and 4 others.

Study type
Systematic review / meta-analysis
Subjects
Human participants (PubMed MeSH: Humans)
Journal
The Cochrane database of systematic reviews
Published
2019 Nov 11
PubMed
PMID 31710397 ↗
DOI
10.1002/14651858.CD008900.pub3 ↗
Full text
Free on PubMed Central (PMC6844361) ↗

Where PepCue cites this

This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.

Cerebrolysin →

Indexed under

MeSH terms assigned by the National Library of Medicine.

Amino AcidsCognitionCost of IllnessDementia, VascularHumansNootropic AgentsQuality of LifeRandomized Controlled Trials as Topic

Other papers on Cerebrolysin

Systematic review / meta-analysis · 2023
Cerebrolysin for acute ischaemic stroke
Randomized controlled trial · 2025
Speech Therapy Combined With Cerebrolysin in Enhancing Nonfluent Aphasia Recovery After Acute Ischemic Stroke: ESCAS Randomized Pilot Study
Review · 2024
Neuroprotective and neuroregenerative drugs after severe traumatic brain injury : A narrative review from a clinical perspective

PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page
Compounds